Drug Safety Matters

51 Episodes

1. #34 Veterinary pharmacovigilance, Part I – James Mount

   Published: 12/17/2024
2. #33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias

   Published: 11/29/2024
3. #32 Pharmacovigilance in older adults – Giovanni Furlan

   Published: 10/25/2024
4. #31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori

   Published: 9/30/2024
5. Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects

   Published: 8/26/2024
6. Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance

   Published: 6/27/2024
7. #30 Preventing and reporting medication errors – Rabat CC & UMC

   Published: 5/15/2024
8. #29 When medicines change our behaviour – Michele Fusaroli

   Published: 4/23/2024
9. #28 Catching black swans – François Montastruc

   Published: 2/29/2024
10. #27 When drugs damage the liver – Rita Baião

    Published: 2/1/2024
11. #26 What's trending in pharmacovigilance? – Angela Caro

    Published: 12/20/2023
12. #25 A week in the name of medicines safety – part 2

    Published: 11/13/2023
13. #24 A week in the name of medicines safety – part 1

    Published: 11/2/2023
14. Uppsala Reports Long Reads – The colour of signals

    Published: 9/29/2023
15. Uppsala Reports Long Reads – Empowering patients as partners

    Published: 9/5/2023
16. #23 Assessing safety in clinical trials – Marianne Lunzer & Sanja Prpić

    Published: 6/27/2023
17. #22 Reforming pharmacovigilance education – Michael Reumerman

    Published: 5/8/2023
18. #21 Unlocking the power of real-world data – Patrick Ryan

    Published: 3/30/2023
19. #20 The evidence for signals – Daniele Sartori

    Published: 2/23/2023
20. Uppsala Reports Long Reads – Unmasking data in the COVID-19 vaccine era

    Published: 1/26/2023